Tour_De_France_steroidsThis year’s Tour de France best climber Bernhard Kohl receives a two-year suspension from the Austrian anti-doping agency (NADA).

Kohl, who also finished third overall in this year’s race, had tested positive for the blood booster CERA, the latest version of exogenous erythropoietin aka EPO.

The 26-year-old rider met with NADA on Nov. 24 and his suspension was announced after the closed door meeting. Contrary to earlier speculation that he will fully cooperate with authorities and reveal his drug source, Kohl did not reveal his drug source.

“Bernhard is willing to cooperate and he will tell about how he got the substance and how and where he used it,” Kohl’s manager Stefan Matschiner stated prior to the meeting with NADA.

The chairman of NADA’s disciplinary committee, Gernot Schaar, said Kohl did not divulge any details on how he got the CERA, a new variant of erythropoietin aka EPO.

“He did not name any names of the men behind his doping use,” Schaar said. “That means there could be no doubt about the penalty.”

Kohl’s could have gotten a lesser penalty had he fully cooperated with authorities.

“I’ve made my statement and I’ve been honest,” Kohl said. “If it’s appreciated (by NADA), it will be a good sign for the sport.”

Kohl was disappointed that he still got the maximum penalty despite coming out clean with his admission.

“It’s a shame that I got the same penalty as someone who denies everything. This is the wrong way. I definitely made clear how I got it and what my reasons behind it were.”

Matschiner, who did not attend the meeting, also expressed his disappointment with the verdict.

“I really hoped his cooperative attitude would have lowered the penalty,” Matschiner was quoted as saying in an interview with Austrian media after the announcement of the ban.